C4 Therapeutics (CCCC) Invested Capital (2020 - 2023)

C4 Therapeutics' Invested Capital history runs 2 years deep, the most recent figure standing at $10.3 million for Q2 2023.

• In Q2 2023, Invested Capital rose 1278.0% year-over-year to $10.3 million; the TTM figure through Mar 2024 stood at $10.3 million (up 36.45% YoY), while the FY2022 annual figure was $2.3 million, changed N/A from the prior year.
• Invested Capital for Q2 2023 stood at $10.3 million, up from $2.3 million in the prior quarter.
• The five-year high for Invested Capital was $10.3 million in Q2 2023, with the low at $750000.0 in Q1 2022.